Fahri Küçükali,Elizabeth Hill,Tijs Watzeels,Holger Hummerich,Tracy Campbell,Lee Darwent,Steven Collins,Christiane Stehmann,Gabor G Kovacs,Michael D Geschwind,Karl Frontzek,Herbert Budka,Ellen Gelpi,Adriano AA Aguzzi,Sven J van der Lee,Cornelia M van Duijn,Pawel P Liberski,Miguel Calero,Pascual Sanchez-Juan,Elodie Bouaziz-Amar,Jean-Louis Laplanche,Stéphane Haïk,Jean-Phillipe Brandel,Angela Mammana,Sabina Capellari,Anna Poleggi,Anna Ladogana,Maurizio Pocchiari,Saima Zafar,Stephanie Booth,Gerard H Jansen,Aušrinė Areškevičiūtė,Eva Løbner Lund,Katie Glisic,Piero Parchi,Peter Hermann,Inga Zerr,Jiri Safar,Pierluigi Gambetti,Brian S Appleby,John Collinge,Kristel Sleegers,Simon H Mead

Abstract:Prions are misfolded prion protein assemblies that cause several fatal and transmissible neurodegenerative diseases, with the most common phenotype in humans being sporadic Creutzfeldt-Jakob disease (sCJD). However, aside from the prion protein itself, molecular risk factors are not well understood. Prion and prion-like mechanisms are thought to underpin common neurodegenerative disorders meaning that the elucidation of mechanisms could have broad relevance. Herein we sought to further develop our understanding of the factors that confer risk of sCJD using a systematic gene prioritization and functional interpretation pipeline based on multiomic integrative analyses. We integrated the published sCJD genome-wide association study (GWAS) summary statistics with publicly available bulk brain and brain cell type gene and protein expression datasets. We performed multiple transcriptome and proteome-wide association studies (TWAS & PWAS) and Bayesian genetic colocalization analyses (coloc) between sCJD risk association signals and multiple brain molecular quantitative trait loci (QTL) signals. We then applied our systematic gene prioritization pipeline on the obtained results and nominated prioritized sCJD risk genes with risk-associated molecular mechanisms in a transcriptome and proteome-wide manner. Genetic upregulation of both gene and protein expression of syntaxin-6 ( ) in the brain was associated with sCJD risk in multiple datasets, with a risk-associated gene expression regulation specific to oligodendrocytes. Similarly, increased gene and protein expression of protein disulfide isomerase family A member 4 ( ), involved in the unfolded protein response, was linked to increased disease risk, particularly in excitatory neurons. Protein expression of mesencephalic astrocyte derived neurotrophic factor ( ), involved in protection against endoplasmic reticulum stress and sulfatide binding (linking to the enzyme in the final step of sulfatide synthesis, encoded by sCJD risk gene ), was identified as protective against sCJD. In total 32 genes were prioritized into two tiers based on level of evidence and confidence for further studies. This study provides insights into the genetically-associated molecular mechanisms underlying sCJD susceptibility and prioritizes several specific hypotheses for exploration beyond the prion protein itself and beyond the previously highlighted sCJD risk loci through the newly prioritized sCJD risk genes and mechanisms. These findings highlight the importance of glial cells, sulfatides and the excitatory neuron unfolded protein response in sCJD pathogenesis.

The Klein–Gordon equation of generalized Hulthén potential in complex quantum mechanics

Abnormal morphology and function in retinal ganglion cells derived from patients-specific iPSCs generated from individuals with Leber's hereditary optic neuropathy.

Hereditary E200K mutation within the prion protein gene alters human iPSC derived cardiomyocyte function

Neuropathologically directed profiling of PRNP somatic and germline variants in sporadic human prion disease

Human Prion Disease with a G114V Mutation and Epidemiological Studies in a Chinese Family: a Case Series

A Chinese Creutzfeldt-Jakob Disease Patient with E196K Mutation in PRNP.

Familial Cjd Associated Prp Mutants Within Transmembrane Region Induced Ctm-Prp Retention In Er And Triggered Apoptosis By Er Stress In Sh-Sy5y Cells

Dopamine and cortical iPSC-derived neurons with different Parkinsonian mutations show variation in lysosomal and mitochondrial dysfunction: implications for protein deposition versus selective cell loss

Multiomic Analyses Direct Hypotheses for Creutzfeldt-Jakob Disease Risk Genes

Altered network and rescue of human neurons derived from individuals with early-onset genetic epilepsy

Functional characterization of a single nucleotide polymorphism associated with Alzheimer's disease in a hiPSC-based neuron model

Genomic Characteristics of Genetic Creutzfeldt-Jakob Disease Patients with V180I Mutation and Associations with Other Neurodegenerative Disorders

[Cordotomy in pain caused by malignancy--the importance of invasive treatment in the preterminal phase].

Pathogenic Prion Protein Isoforms Are Not Present in Cerebral Organoids Generated from Asymptomatic Donors Carrying the E200K Mutation Associated with Familial Prion Disease

Elevated E200K Somatic Mutation of the Prion Protein Gene (PRNP) in the Brain Tissues of Patients with Sporadic Creutzfeldt–Jakob Disease (CJD)

Familial Creutzfeld-Jakob disease, compatible with PRNP c.532G>A (p.Asp178sn) gene mutation

Single‐Cell Patch‐Clamp/Proteomics of Human Alzheimer's Disease iPSC‐Derived Excitatory Neurons Versus Isogenic Wild‐Type Controls Suggests Novel Causation and Therapeutic Targets

An experimental geneticist looks at catecholamine metabolism

DNA Generated Electric Current Biosensor.

A perspective on human cell models for POLG-spectrum disorders: advantages and disadvantages of CRISPR-Cas-based vs. patient-derived iPSC models

Rare E196A mutation in PRNP gene of 3 Chinese patients with Creutzfeldt-Jacob disease